These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31676)

  • 1. The influence of salicyl-azo-sulfapyridine on the immune response to antigenic tumour cells inoculated into the coecal lumen of C3H mice.
    Laursen ML
    Scand J Gastroenterol; 1978; 13(8):991-7. PubMed ID: 31676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological enhancement induced by gastrointestinal immunization of mice pretreated with cyclophosphamide.
    Laursen ML
    J Cancer Res Clin Oncol; 1980; 96(3):231-41. PubMed ID: 7000791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour sensitization obtained by injection of antigenic tumour cells into the caecal lumen of syngeneic mice.
    Laursen ML; Laursen K
    Eur J Cancer (1965); 1979 Apr; 15(4):537-42. PubMed ID: 436914
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route.
    Laursen ML; Laursen K
    Br J Cancer; 1978 Jun; 37(6):1039-45. PubMed ID: 678425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological response to intracaecal injections of antigenic mouse tumour cells.
    Laursen ML
    Br J Cancer; 1978 Dec; 38(6):692-8. PubMed ID: 369587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization by the intestinal route of C3H-mice against C3H-L-ascites tumor cells.
    Laursen ML; Laursen K
    Proc Soc Exp Biol Med; 1977 Feb; 154(2):314-7. PubMed ID: 840870
    [No Abstract]   [Full Text] [Related]  

  • 7. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production.
    Isakov N; Segal S; Hollander N; Feldman M
    Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence on antigen dose and timing in the immune response of C3H mice to malignant ascites cells.
    Laursen ML; Laursen K
    Immunology; 1980 Jul; 40(3):403-10. PubMed ID: 7429535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liberation of non-specific cytotoxic factors during the establishment of immunity against a murine allogeneic tumour.
    Vaillier D; Donner M; Vaillier J; Burg C
    Int Arch Allergy Appl Immunol; 1972; 43(6):871-8. PubMed ID: 4660315
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Int J Cancer; 1979 Mar; 23(3):358-65. PubMed ID: 437918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competition for cytotoxic immune capacity against a 'syngeneic' mouse tumour distributed at two sites.
    Chassoux D; MacLennan IC; Munro TR
    Int J Cancer; 1977 Jun; 19(6):796-802. PubMed ID: 873644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour.
    Chassoux DM; Gotch FM; MacLennan IC
    Br J Cancer; 1978 Aug; 38(2):211-8. PubMed ID: 698035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice.
    Bekesi JG; Roboz JP; Holland JF
    Isr J Med Sci; 1976; 12(4-5):288-303. PubMed ID: 181351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of mice against syngeneic lymphomata: I. Use of antibodies.
    Davies DA; Manstone AJ; Buckham S
    Br J Cancer; 1974 Oct; 30(4):297-304. PubMed ID: 4217193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.
    Shellam GR; Fahey KJ
    Adv Exp Med Biol; 1973; 29(0):411-7. PubMed ID: 4211985
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum factor levels during the growth of rat hepatoma nodules in the lungs.
    Bowen JG; Baldwin RW
    Int J Cancer; 1976 Feb; 17(2):254-60. PubMed ID: 175030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A time factor in the success or failure of immune rejection of transplanted tumors.
    Vaage J
    Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of immunity to murine salmonellosis: studies involving immunization with lipopolysaccharide-lipid A-associated protein complexes in C3H/HeJ mice.
    Killion JW; Morrison DC
    FEMS Microbiol Immunol; 1988 Jan; 1(1):41-53. PubMed ID: 3272826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.